Skip to main content
TipRanks
Go Ultimate75% OFF

Spyre Therapeutics (SYRE) Ownership - Who Owns Spyre Therapeutics?

586 Followers

Spyre Therapeutics (SYRE) Ownership Overview

  • 1.61% Insiders
  • 28.58% Mutual Funds
  • 51.03% Other Institutional Investors
  • 15.81% ETFs
  • 2.97% Public Companies and Individual Investors

The ownership structure of Spyre Therapeutics (SYRE) stock is a mix of institutional, retail, and individual investors. Approximately 95.42% of the company’s stock is owned by Institutional Investors, 1.61% is owned by Insiders, and 2.97% is owned by Public Companies and Individual Investors.

Institutional holdings as of (latest 13F reporting period).

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue
Oct 01, 2026Scott L Burrows$1,573,075
Jun 25, 2026Scott L Burrows$1,307,000
Jun 22, 2026Fairmount Funds Management Llc$399,658,667

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue
Sep 30, 2026Perceptive Advisors Llc$292,102,355
Sep 30, 2026Driehaus Capital Management Llc$245,762,685
Sep 30, 2026Blackstone Inc.$15,675,423
Sep 30, 2026Woodline Partners Lp$25,541,906

Top Shareholders

SYRE top shareholders
Holder# of SharesType% HoldingValue
Vanguard7,003,135Institution7.37%683,716,070
BlackRock, Inc.6,779,486Institution7.14%661,881,218
Vanguard Index Funds4,832,758Institution5.09%471,822,164
Fidelity Mt. Vernon Street Trust4,276,963Institution4.50%417,559,898
Peter Harwin4,018,101Institution4.23%392,287,201
Ishares3,809,132Institution4.01%371,885,557
Joseph Edelman3,280,943Institution3.45%320,318,465
Smallcap World Fund Inc2,780,536Institution2.93%271,463,730
Steve Weber2,760,448Institution2.91%269,502,538
Spdr2,008,864Institution2.12%196,125,392

Top Mutual Fund Holders

SYRE top mutual fund holders
Holder# of SharesType% HoldingValue
Vanguard Index Funds4,832,758Institution5.09%471,822,164
Fidelity Mt. Vernon Street Trust4,276,963Institution4.50%417,559,898
Smallcap World Fund Inc2,780,536Institution2.93%271,463,730
Fidelity Securities Fund1,592,057Institution1.68%155,432,525
Fidelity Advisor Series Vii1,197,347Institution1.26%116,896,988
Fidelity Salem Street Trust1,104,333Institution1.16%107,816,031
Fidelity Select Portfolios1,090,057Institution1.15%106,422,265
Fidelity Concord Street Trust825,799Institution0.87%80,622,756
T. Rowe Price Health Sciences Fund, Inc.711,845Institution0.75%69,497,427
T. Rowe Price New Horizons Fund, Inc.673,799Institution0.71%65,782,996

Top ETF Holders

SYRE top ETF holders
Holder# of SharesType% HoldingValue
Vanguard Total Stock Market ETF, VTI ETF2,106,590Institution2.22%203,412,330
iShares Russell 2000 ETF, IWM ETF1,992,748Institution2.10%194,551,987
Vanguard Small-Cap ETF, VB ETF1,878,002Institution1.98%181,339,873
SPDR S&P BIOTECH ETF, XBI ETF1,751,926Institution1.84%177,750,412
Vanguard Small Cap Value ETF, VBR ETF1,220,725Institution1.29%117,873,206
Vanguard Extended Market ETF, VXF ETF940,056Institution0.99%90,771,807
iShares Russell 2000 Growth ETF, IWO ETF721,491Institution0.76%70,439,166
iShares Biotechnology ETF, IBB ETF617,696Institution0.65%60,305,660
Vanguard Russell 2000 ETF, VTWO ETF449,552Institution0.47%43,408,741
Schwab U.S. Small-Cap ETF, SCHA ETF442,493Institution0.47%44,895,340

FAQ

Who Owns Spyre Therapeutics (SYRE)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 95.42% of the company's stock is held by institutional investors, 1.61% is held by insiders, and 2.97% is held by public companies and individual investors.
What percentage of Spyre Therapeutics (SYRE) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 95.42% of Spyre Therapeutics (SYRE) stock is held by institutional investors: 28.58% by mutual funds, 15.81% by ETFs and 51.03% by other institutional investors.
What percentage of Spyre Therapeutics (SYRE) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 2.97% of Spyre Therapeutics (SYRE) stock is held by public companies and individual investors.
Who owns the most shares of Spyre Therapeutics (SYRE)?
Vanguard owns the most shares of Spyre Therapeutics (SYRE).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.